Corbus Pharmaceuticals Holdings, Inc. (CRBP) — Stock Score Summary

Corbus Pharmaceuticals Holdings, Inc. (CRBP) has a MoatMap StockRank of 14/100 based on Quality (33/100), Value (41/100), and Momentum (24/100) factor scores. The current signal is STRONG SELL. Corbus is a microcap biotech with no approved products or structural cash flows, making it a speculative vehicle rather than a quality compounder.

Corbus Pharmaceuticals Holdings, Inc. is a clinical-stage pharmaceutical company developing novel small molecule therapies for inflammatory, fibrotic, and cancer indications. The company focuses on targeting specific biological pathways to address diseases with high unmet medical needs. Its pipeline, including agents for oncology and rare diseases, positions it in the competitive biotechnology landscape.

Key Financial Metrics

Price$7.38
Market Cap$142M
P/E (Forward)-1.58
Price/Book1.12
Return on Equity-66.7%
Return on Invested Capital-53.2%
Debt/Equity0.95
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-43M

Corbus Pharmaceuticals Holdings, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Corbus Pharmaceuticals Holdings, Inc.’s (CRBP) StockRank?
MoatMap’s StockRank for Corbus Pharmaceuticals Holdings, Inc. (CRBP) is 14/100, with a Strong Sell signal. It is a composite of Quality (33), Value (41), and Momentum (24) factor ranks across MoatMap’s 19,000+ stock universe.
Does Corbus Pharmaceuticals Holdings, Inc. have an economic moat?
Corbus Pharmaceuticals Holdings, Inc. (CRBP) has a Quality factor score of 33/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Corbus Pharmaceuticals Holdings, Inc. a buy, hold, or sell?
MoatMap’s current signal for Corbus Pharmaceuticals Holdings, Inc. (CRBP) is Strong Sell, based on a StockRank of 14/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Corbus Pharmaceuticals Holdings, Inc. in?
Corbus Pharmaceuticals Holdings, Inc. (CRBP) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksCRBP deep dive reportAI ChampionsHow we score stocksSense-check another stock